Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls-Reference-Cited by-同舟云学术

Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls

Published:1997-05 Issue:1 Volume:17 Page:61-68
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Shaw Gail L.,Weiffenbach Barbara,Falk Roni T.,Frame James N.,Issaq Haleem J.,Moir Donald T.,Caporaso Neil

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. Debrisoquin oxidation genotype and susceptibility to lung cancer;Agúndez;Clin Pharmacol Ther,1994

2. Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene;Broly;Pharmacogenetics,1993

3. The determination of debrisoquine and its 4-hydroxy metabolite in urine by capillary gas chromatography and high performance liquid chromatography;Fox;J Liq Chromatogr,1993

4. Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism;Gaedigk;Am J Hum Genet,1991

5. Molecular genetics of the debrisoquine-sparteine polymorphism;Gonzalez;Clin Pharmacol Ther,1991

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline mutations predisposing to non-small cell lung cancer;Familial Cancer;2015-03-27

2. Cytochrome P450 Gene Polymorphism and Cancer;Current Drug Metabolism;2004-06-01

3. Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia;Journal of Clinical Pharmacy and Therapeutics;2003-08

4. Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes;Pharmacogenetics;2000-04